Global Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Analysis
March 22, 2022 07:18 ET | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication End User" report has been added to...
immucor.jpg
Immucor Announces New Innovations in Transplant Diagnostics
March 04, 2022 13:18 ET | Immucor, Inc.
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio,...
Celebrate Mother’s Day With the Gift of Life-Saving Cord Blood Donation
April 30, 2021 16:59 ET | Parent’s Guide to Cord Blood Foundation
BROOKEVILLE, Md., April 30, 2021 (GLOBE NEWSWIRE) -- As we look toward celebrating Mother’s Day on May 9, we recognize all of the very many ways moms love their children, provide endless hours of...
22157.jpg
Global Cord Blood Banking Industry Report 2021: Holding Companies are Emerging as a Global Theme
January 11, 2021 07:38 ET | Research and Markets
Dublin, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. From the early 1900s through the...
22157.jpg
Global Cord Blood Banking Industry Report 2020: Trends, Expansion Technologies, Key Strategies, Regional Insights
August 31, 2020 06:59 ET | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2020" report has been added to ResearchAndMarkets.com's offering.This report presents the number of cord...
Reports and Data.jpeg-01
Acute Myeloid Leukemia Therapeutics Market To Reach USD 3.56 Billion By 2027 | Reports And Data
July 22, 2020 15:04 ET | Reports and Data
New York, July 22, 2020 (GLOBE NEWSWIRE) -- Market Size – USD 1.46 Billion in 2019, Market Growth - CAGR of 13.1%, Market Trends – Implementing various growth strategies in therapeutics. New York,...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual Meeting
November 08, 2019 07:00 ET | Bellicum Pharmaceuticals, Inc.
iMC activation enhances innate NK cell cytotoxicity against tumor cell lines in vitro MC activity enhances the efficacy of CAR-NK cells against hematological and solid tumor models MC signaling...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Operational Update
November 06, 2019 16:15 ET | Bellicum Pharmaceuticals, Inc.
Raised gross proceeds of $69.6 million from public offering and private placement option fee Narrowed strategic focus to core GoCAR-T® cell therapy programs Cost saving initiatives underway to...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2019 16:07 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 30, 2019 16:08 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...